GlassScriptPhysician profile
Charles J Adelmann
NPI 1861436511
$2,207.31
in general payments reported to CMS, 2019-2025
13 companies · $1,116 in 2025
The $1,116 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2021: $14.86 · 2022: $16.14 · 2024: $900 · 2025: $1,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,016.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $936.65 | 2024-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $437.29 | 2024-2025 | Tremfya, Stelara, Simponi |
| Ardelyx, INC. | $178.17 | 2024-2025 | Ibsrela |
| Braintree Laboratories, INC. | $159.96 | 2019 | |
| Phathom Pharmaceuticals, INC. | $125.00 | 2024 | Voquezna |
| Abbvie INC. | $113.20 | 2024-2025 | |
| Madrigal Pharmaceuticals | $63.31 | 2025 | Rezdiffra |
| Celgene Corporation | $55.80 | 2024 | Zeposia |
| Genzyme Corporation | $51.30 | 2024-2025 | |
| Lilly USA, LLC | $36.10 | 2025 | Omvoh |
| Exact Sciences Corporation | $19.53 | 2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $16.14 | 2022 | |
| Boston Scientific Corporation | $14.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Adelmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.